SUMMARY Twenty-eight cases of acute anterior uveitis in which raised antibody titres indicated yersinia infection as a possible causative factor in the disease were studied retrospectively. In most cases the antibodies belonged to the IgA class; in only 6 patients did the presence AAU related to yersinia infection has not been earlier studied as a separate entity. For instance, it is not known how frequently yersinia infection is the cause of AAU and whether these cases are characterised by special clinical and immunological features. The purpose of the present work was to elucidate these questions by analysing retrospectively 28 cases of AAU in which elevated antibody titres indicated yersinia infection as a possible causative factor in the disease. We have studied the ocular pathology, the rate of recurrence, and the overall prognosis of these cases, and paid special attention to the presence of certain clinical features, such as diarrhoea and arthritis.
SUMMARY Twenty-eight cases of acute anterior uveitis in which raised antibody titres indicated yersinia infection as a possible causative factor in the disease were studied retrospectively. In most cases the antibodies belonged to the IgA class; in only 6 patients did the presence of IgM class antibodies indicate recent infection. In half the cases also antibody titres against Chlamydia were raised. The clinical features and course of the disease did not differ from those of acute anterior uveitis due to other causes.
Acute anterior uveitis (AAU) is a common disease usually affecting young or middle-aged patients. It frequently occurs in connection with other disorders such as Reiter's disease, ankylosing spondylitis, juvenile rheumatoid arthritis, psoriatic arthritis, and sarcoidosis. It may also follow certain infections-for example, by Chlamydia trachomatis, salmonella, or yersinia-as a late complication.`'-It is noteworthy that AAU and several of the other disorders mentioned above are correlated with the presence ofHLA B27. 4 This has also been demonstrated for the reactive arthritis that develops after acute enteritis caused by yersinia." AAU related to yersinia infection has not been earlier studied as a separate entity. For instance, it is not known how frequently yersinia infection is the cause of AAU and whether these cases are characterised by special clinical and immunological features. The purpose of the present work was to elucidate these questions by analysing retrospectively 28 cases of AAU in which elevated antibody titres indicated yersinia infection as a possible causative factor in the disease. We have studied the ocular pathology, the rate of recurrence, and the overall prognosis of these cases, and paid special attention to the presence of certain clinical features, such as diarrhoea and arthritis.
Patients and methods
The subjects of the study were 15 women and 13 men with AAU who had significant amounts of antiyersinia antibodies in their sera. They were examined at the outpatient department of the Clinic for Ophthalmology at Turku University from March 1979 to September 1980. Patients who had AAU due to ocular trauma were excluded from the study.
The diagnosis of AAU was in all cases confirmed by biomicroscopic examination. The following laboratory tests were carried out on each patient: erythrocyte sedimentation rate (ESR), peripheral blood leucocyte count, the latex and Waaler-Rose test for rheumatoid factor, antistreptolysin 0, antistaphylolysin, anti-yersinia-antibody, and antichlamydia antibody determinations, and x-ray examination of the chest, sinuses, and lumbosacral spine. The hospital records were reviewed with attention to the severity of the AAU and its course as well as possible recurrences and associated diseases.
The ELISA method (enzyme-linked immunosorbent assay) for IgM, IgG, and IgA class yersinia antibodies has been described in detail previously.'" In brief, the assay was a double antibody utilising immunoglobulin class-specific rabbit antihuman sera and swine antirabbit IgG alkaline phosphatase conjugate. The antigen preparations used were formalinised whole Y. enterocolitica 0:3 and Y. pseudotuberculosis IA bacteria " and heat-treated (100°C for 1 h) Y. enterocolitica 0:9 bacteria. The results were evaluated by means of a standard curve constructed from measurements on 6 different dilutions of serum with a high concentration of the corresponding antibody to yersinia. The results are presented as percentage values of the standard serum.
to affect both sexes equally. The patients represent primarily young and middle-aged people, the mean age being 38. The youngest patient was 17 and the oldest 65 years old. The mean age of the women was 36 years (range 23-64) and of men 43 years (range 17-65 years).
The AAU was bilateral in 6 patients. In 9 cases (32%) there had previously been AAU. The ocular pathology and the duration of the symptoms in patients who had raised anti-yersinia antibodies did not differ from the other cases of AAU treated at the same time in the Clinic for Ophthalmology. In no case was a relapse observed during the relatively short follow-up period. In only one patient was the disease so severe that systemic steroid treatment was given. All others were treated by topical mydriatics and corticosteroids. Three patients received tetracycline because of fresh arthritis and/or diarrhoea. The one patient who had systemic corticosteroid therapy received tetracycline.
The results of the laboratory tests are presented in Table 1 . It is remarkable that none of the patients had a positive latex test for rheumatoid factor and only one had a positive Waaler-Rose test. The ESR remained low in most patients, and only in 2 cases was it over 40 mm/h. The other laboratory tests did not reveal any significant changes typical of AAU. In 3 patients ankylosing spondylitis was also diagnosed at this time; its duration could not be established with certainty.
The clinical features of interest in the patients are summarised in Table 2 . The raised yersinia antibodies belonged in most cases to the IgA class, and only in 6 patients were the IgM antibodies raised, indicating a recent infection by yersinia. In most cases the antibodies were against Y. enterocolitica 3, in 4 against Y. enterocolitica 9, and in 3 patients against Y. pseudotuberculosis IA. Five patients (17-9%) had had diarrhoea in the initial phase, and in 3 cases (10-7%) the patient had reactive arthritis. One of those 3 patients also had raised antibodies against chlamydia in a titre of 1:32.
In 7 cases high antibody titres > 1:32 against chlamydia were observed; this represents 25% of the whole material (Table 1) . A further 7 patients had lower anti-chlamydia antibody titres of > 1:16. Taken together, 50% of the patients thus had raised antibody titres both against yersinia and chlamydia. The question therefore arose whether these 2 agents have cross-reacting or common antigens or whether the patient had 2 infections simultaneously. The 7 sera with high antibody levels against both agents were absorbed with yersinia; in 6 cases the absorption caused no drop in the anti-chlamydia titres. One serum lost its anti-chlamydia titre of 1:128 when absorbed with yersinia. This serum is being studied further to find out whether the antibody is truly crossreactive. Anyway it is apparent that generally the appearance of. antibodies against both yersinia and chlamydia indicates double infection.
Discussion
Our observations indicate that AAU after yersinia infection does not clinically differ from that caused by other aetiological factors. Only 5 patients had had diarrhoea that suggested the possibility of yersinia as primary cause of the disease. This is in concordance with the clinical observation that, in patients who later develop arthritis, diarrhoea is not a prominent initial symptom. Interestingly, relapsing AAU is not restricted to the same eye but may affect one or the other. It seems therefore that some unknown factor is needed to trigger the inflammatory process in the eye.
In 26 of the 28 cases the IgA class antibodies against yersinia were raised and only in 12 cases were high levels of IgG class antibodies observed. Of these, 2 had the IgG antibodies as the only class present in their sera. In 6 patients high IgM class antibodies indicated that the yersinia infection had been recent. The observation is in accordance with the findings that in yersinia arthritis the IgA class antibodies are high and remain elevated for prolonged periods even after the actual joint symptoms have disappeared.9 1516 The reason for this phenomenon remains unclear, and persistence of the antigen in the organism, for example, has not been demonstrated. In any case it is obvious that high IgA anti-yersinia antibodies are correlated with the occurrence of postinfectious complications, although their role remains obscure.
The present material indicates that yersinia infection as a cause of postinfectious AAU is far less common than chlamydia infection. In the present series as many as 14 (50%) patients had antichlamydia antibodies, 7 (25%) of these at a high level. The same high incidence of anti-chlamydia antibodies has been observed also in another follow-up study in our clinic,' whereas out of 121 consecutive cases of AAU only 13 (10-7%) could be considered as caused by yersinia. Moreover, 3 patients in our material had as an underlying disease ankylosing spondylitis, to which AAU is known to be correlated. The absorption studies of the sera show that at least in 6 out of the 7 cases studied the patient had both chlamydia and yersinia infection simultaneously. It is not possible to conclude whether one of the 2 or both infections together caused the AAU.
A practical problem related both to the arthritis and AAU after yersinia infection is the possible need of antibiotic treatment. It seems that in both diseases3 141 7 the bacteria disappear quickly from the stools and the diagnosis has to be based on the demonstration of antibodies; in our material stool cultures were not carried out. The same holds true also for chlamydia, which can rarely be isolated at the time of diagnosis of AAU.' In the present study 4 patients received tetracyclines and the others were treated only with topical mydriatics and steroids. 
